Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German lung cancer incidence rises in women:

This article was originally published in Clinica

Executive Summary

The incidence of lung cancer in German women has risen dramatically in the last two decades, and while prevention following cutting out or down on tobacco has been successful in men, in women the same cannot be claimed. So says Christa Stegmaier, the head of the epidemiological cancer registry of the state of Saarland. Citing figures that are claimed to be representative for the whole of Germany, she said that lung cancer in Saarland women has risen by 173% in the last 20 years. A quarter of female lung cancer deaths were in the under-60 age bracket. Breast cancer is the leading female cancer in the state. In males, increased screening has seen prostate cancer overtake lung cancer as the leading form of the disease. Several thousand men had opted to take PSA tests under a programme organised by the Homburg Uniclinic, she said.

You may also be interested in...



Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel